Evidence map›Paper›PMID 33267070›Full record

ArticleEntropy (Basel, Switzerland)2019

First-Stage Prostate Cancer Identification on Histopathological Images: Hand-Driven versus Automatic Learning.

Gabriel García, Adrián Colomer, Valery Naranjo

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gabriel GarcíaInstituto de Investigación e Innovación en Bioingeniería (I3B), Universitat Politècnica de València (UPV), Camino de Vera s/n, 46008 Valencia, Spain.ORCID 0000-0001-9900-886X
Adrián ColomerInstituto de Investigación e Innovación en Bioingeniería (I3B), Universitat Politècnica de València (UPV), Camino de Vera s/n, 46008 Valencia, Spain.
Valery NaranjoInstituto de Investigación e Innovación en Bioingeniería (I3B), Universitat Politècnica de València (UPV), Camino de Vera s/n, 46008 Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analysis of histopathological image supposes the most reliable procedure to identify prostate cancer. Most studies try to develop computer aid-systems to face the Gleason grading problem. On the contrary, we delve into the discrimination between healthy and cancerous tissues in its earliest stage, only focusing on the information contained in the automatically segmented gland candidates. We propose a hand-driven learning approach, in which we perform an exhaustive hand-crafted feature extraction stage combining in a novel way descriptors of morphology, texture, fractals and contextual information of the candidates under study. Then, we carry out an in-depth statistical analysis to select the most relevant features that constitute the inputs to the optimised machine-learning classifiers. Additionally, we apply for the first time on prostate segmented glands, deep-learning algorithms modifying the popular VGG19 neural network. We fine-tuned the last convolutional block of the architecture to provide the model specific knowledge about the gland images. The hand-driven learning approach, using a nonlinear Support Vector Machine, reports a slight outperforming over the rest of experiments with a final multi-class accuracy of 0.876 ± 0.026 in the discrimination between false glands (artefacts), benign glands and Gleason grade 3 glands.

Indexed as

deep learningfeature selectiongland classificationhand-crafted feature extractionhand-driven learninghistological imageprostate cancer

Identifiers

PMID33267070
PMCPMC7514840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.